Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remimazolam for Pediatric Anesthesia Induction (DRINK)
NCT05990673Unknown
- Start
- Aug 2023
- Primary completion
- Sep 2023
- Modality
- Small Molecules
01
Overview
Trial of remimazolam. Primary endpoint: 50% Effective Dose at 5 minutes. Status: unknown.
02
Drugs
remimazolam
Beyond the preview
Go deeper on NCT05990673.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05990673.